Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB
Conditions
Tuberculosis, Pulmonary
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Isango Lethemba TB Research Unit, Port Elizabeth, Bethelsdorp, South Africa
Contact: Principal Investigator (Simone Faesen, MD)Setshaba Research Centre, Pretoria, Guateng, South Africa
Contact: Principal Investigator (Zinhle Zwane, MD)University of Capetown Lung Institute, Cape Town, Mowbray, South Africa
Contact: Study coordinator (Sherman PadayaChee, MD) · Sherman.Padayachee@uct.ac.za · +27 21 404 7747Contact: Principal Investigator (Sherman Padayachee, MD)The Aurum Institute, Rustenburg, Rustenburg, North West, South Africa
Contact: Study coordinator (William Brumskine, MD)Contact: Study coordinator (William Brumskine, MD) · wbrumskine@auruminstitute.org · +27 87 135 1575Contact: Principal Investigator (William Brumskine, MD)Madiberg Centre for Research, Brits, North West Provinvce, South Africa
Contact: Principal Investigator (Lindsey Faul, MD)Durban International Clinical Research Site, Enhancing Care Foundation, Durban, Wentworth, South Africa
Contact: Principal Investigator (Umesh Lalloo, MD)Synergy Biomed Research Institute, East London, South Africa
Contact: Principal Investigator (Mookho Malahleha, MD)INUKA Africa, Dar es Salaam, Tanzania
Contact: Principal Investigator (Frederik Haraka, MD)Mbeya Referral Hospital, Mbeya, Tanzania
Contact: Study coordinator (Christina Manyama, MD) · christina.manyama@nimr.or.tz · +255 25 250 3364Contact: Principal Investigator (Christina Manyama, MD)Kilimanjaro Clinical Research Instuute, Moshi, Tanzania
Contact: Principal Investigator (Blandina Mmbaga, MD)National Instittute for Medical Research, Mwanza, Tanzania
Contact: Principal Investigator (Kidola Jeremiah, MD)
Study leads
Morounfolu Olugbosi
Study Director
TB Alliance